Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion

Journal of Experimental Medicine

Volumn 196, Issue 6, 2002, Pages 841-850

  Bandeira Melo, Christianne ^a   Woods, Lesley J ^a   Phoofolo, Mojabeng ^a   Weller, Peter F ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

5 lipoxygenase; Eotaxin; Interleukin 16; Leukotriene C4; RANTES

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ARACHIDONATE 5 LIPOXYGENASE; CALPHOSTIN C; CHELERYTHRINE; CHEMOKINE RECEPTOR CCR3; EOTAXIN; G PROTEIN COUPLED RECEPTOR; GENISTEIN; HERBIMYCIN; INTERLEUKIN 16; INTERLEUKIN 4; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; PEPTIDOLEUKOTRIENE; RANTES; STAUROSPORINE; WORTMANNIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DEGRANULATION; EOSINOPHIL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; MEMBRANE VESICLE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ARACHIDONATE 5-LIPOXYGENASE; EOSINOPHILS; HUMANS; INTERLEUKIN-4; LEUKOTRIENE C4; LEUKOTRIENE D4; MEMBRANE PROTEINS; RANTES; RECEPTORS, CHEMOKINE; RECEPTORS, LEUKOTRIENE; TRANSPORT VESICLES;

EID: 0037120054     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20020516     Document Type: Article

References (50)

1. Wardlaw, A.J. 1999. Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm. J. Allergy Clin. Immunol. 104:917-926.
2. Gleich, G.J. 2000. Mechanisms of eosinophil-associated inflammation. J. Allergy Clin. Immunol. 105:651-663.
3. Weller, P.F. 1993. Lipid, peptide and cytokine mediators elaborated by eosinophils. In Immunopharmacology of eosinophils. The Handbook of Immunopharmacology. J.H. Smith and R.M. Cook, editors. Academic Press, London. 25-42.
4. Lewis, R.A., K.F. Austen, and R.J. Soberman. 1990. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 323:645-655.
5. Henderson, W.R., Jr. 1994. The role of leukotrienes in inflammation. Ann. Intern. Med. 121:684-697.
6. 4 and granulocytic infiltration into asthmatic airways. Lancet. 341:989-990.
7. Lacy, P., and R. Moqbel. 2000. Eosinophil cytokines. Chem. Immunol. 76:134-155.
8. Lim, K.G., H.-C. Wan, P.T. Bozza, M.B. Resnick, D.T.W. Wong, W.W. Cruikshank, H. Kornfeld, D.M. Center, and P.F. Weller. 1996. Human eosinophils elaborate the lymphocyte chemoattractants: IL-16 (lymphocyte chemoattractant factor, LCF) and RANTES.J. Immunol. 156:2522-2527.
9. Nakajima, T., H. Yamada, M. Iikura, M. Miyamasu, S. Izumii, H. Shida, K. Ohta, T. Imai, O. Yoshie, M. Mochizuki, et al. 1998. Intracellular localization and release of eotaxin from normal eosinophils. FEBS Lett. 434:226-230.
10. + T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J. Immunol. 158:3539-3544.
11. Moqbel, R., S. Ying, J. Barkans, T.M. Newman, P. Kimmitt, M. Wakelin, L. Taborda-Barata, Q. Meng, C.J. Corrigan, S.R. Durham, and A.B. Kay. 1995. Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J. Immunol. 155:4939-4947.
12. Brown, M.A., and J. Hural. 1997. Functions of IL-4 and control of its expression. Crit. Rev. Immunol. 17:1-32.
13. Nelms, K., A.D. Keegan, J. Zamorano, J.J. Ryan, and W.E. Paul. 1999. The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17:701-738.
14. Lacy, P., S. Mahmudi-Azer, B. Bablitz, S.C. Hagen, J.R. Velazquez, S.F.P. Man, and R. Moqbel. 1999. Rapid mobilization of intracellularly stored RANTES in response to interferon-g in human eosinophils. Blood. 94:23-32.
15. Bandeira-Melo, C., G. Gillard, I. Ghiran, and P.F. Weller. 2000. Eli Cell: a solid-phase dual antibody capture and detection assay to detect cytokine release by eosinophils. J. Immunol. Methods. 244:105-115.
16. Bandeira-Melo, C., K. Sugiyama, L.J. Woods, and P.F. Weller. 2001. Cutting edge: eotaxin elicits rapid, vesicular transport-mediated release of preformed IL-4 from human eosinophils. J. Immunol. 166:4813-4817.
17. Bandeira-Melo, C., P.T. Bozza, and P.F. Weller. 2002. The cellular biology of eosinophil eicosanoid formation and function. J. Allergy Clin. Immunol. 109:393-400.
18. 4 synthase. Organization, nucleotide sequence, and chromosomal localization to 5q35. J. Biol. Chem. 271:11356-11361.
19. 4 synthesis accompanies adherence-dependent nuclear import of 5-lipoxygenase in human blood eosinophils. J. Immunol. 162: 1669-1676.
20. 4 production in eosinophils and basophils. J. Biol. Chem. 276:22779-22787.
21. 4 by human eosinophils. J. Biol. Chem. 264:12885-12889.
22. 4 synthesis in vivo and attenuation of the acute inflammatory response. Mol. Cell. Biol. 21:5389-5395.
23. 4 and gamma-glutamyl amino acids. Proc. Natl. Acad. Sci. USA. 79:1088-1091.
24. 4 by a dipeptidase released from the specific granule of human polymorphonuclear leucocytes. Immunology. 48:27-35.
25. Lynch, K.R., G.P. O'Neill, Q. Liu, D.S. Im, N. Sawyer, K.M. Metters, N. Coulombe, M. Abramovitz, D.J. Figueroa, Z. Zeng, et al. 1999. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature. 399:789-793.
26. Sarau, H.M., R.S. Ames, J. Chambers, C. Ellis, N. Elshourbagy, J.J. Foley, D.B. Schmidt, R.M. Muccitelli, O. Jenkins, P.R. Murdock, et al. 1999. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. Mol. Pharmacol. 56:657-663.
27. Nothacker, H.P., Z. Wang, Y. Zhu, R.K. Reinscheid, S.H. Lin, and O. Civelli. 2000. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist. Mol. Pharmacol. 58: 1601-1608.
28. 2) receptor. J. Biol. Chem. 275: 30531-30536.
29. Mellor, E.A., A. Maekawa, K.F. Austen, and J.A. Boyce. 2001. Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proc. Natl. Acad. Sci. USA. 98:7964-7969.
30. Mellor, E.A., K.F. Austen, and J.A. Boyce, 2002. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. J. Exp. Med. 195:583-592.
31. 4 binding site not coupled to contraction in human lung parenchyma. Mol. Pharmacol. 57:1182-1189.
32. 4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am. J. Respir. Cell Mol. Biol. 19:453-461.
33. Lee, E., T. Robertson, J. Smith, and S. Kilfeather. 2000. Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals. Am. J. Respir. Crit. Care Med. 161:1881-1886.
34. Urasaki, T., J. Takasaki, T. Nagasawa, and H. Ninomiya. 2001. Pivotal role of 5-lipoxygenase in the activation of human eosinophils: platelet-activating factor and interleukin-5 induce CD69 on eosinophils through the 5-lipoxygenase pathway. J. Leukoc. Biol. 69:105-112.
35. Figueroa, D.J., R.M. Breyer, S.K. Defoe, S. Kargman, B.L. Daugherty, K. Waldburger, Q. Liu, M. Clements, Z. Zeng, G.P. O'Neill, et al. 2001. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am. J. Respir. Crit. Care Med. 163:226-233.
36. 2 receptors EP3 and EP4 in the nuclear envelope. J. Biol. Chem. 274:15719-15724.
37. Wright, D.H., D. Abran, M. Bhattacharya, X. Hou, S.G. Bernier, A. Bouayad, J.C. Fouron, A. Vazquez-Tello, M.H. Beauchamp, R.I. Clyman, et al. 2001. Prostanoid receptors: ontogeny and implications in vascular physiology, Am. J. Physiol. Regul. Integr. Comp. Physiol. 281:R1343-R1360.
38. Peters-Golden, M., and T.G. Brock. 2000. Intracellular compartmentalization of leukotriene biosynthesis. Am. J. Respir. Crit. Care Med. 161:S36-S40.
39. 4 and interleukin-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine mediated signaling. J. Immunol. 168: 4756-4763.
40. Schultz, M.J., J. Wijnholds, M.P. Peppelenbosch, M.J. Vervoordeldonk, P. Speelman, S.J. van Deventer, P. Borst, and T. van der Poll. 2001. Mice lacking the multidrug resistance protein 1 are resistant to Streptococcus pneumoniae-induced pneumonia. J. Immunol. 166:4059-4064.
41. Bozza, P.T., J.L. Payne, J.L. Goulet, and P.F. Weller. 1996. Mechanisms of PAF-induced lipid body formation: a central role for 5-lipoxygenase in the compartmentalization of leukocyte lipids. J. Exp. Med. 183:1515-1525.
42. Bartemes, K.R., S. McKinney, G.J. Gleich, and H. Kita. 1999. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG. J. Immunol. 162:2982-2989.
43. 4 export carrier in mastocytoma cells. Eur. J. Biochem. 220:599- 606.
44. 4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem. Biophys. Res. Commun. 208:345-352.
45. Wijnholds, J., R. Evers, M.R. van Leusden, C.A. Mol, G.J. Zaman, U. Mayer, J.H. Beijnen, M. van der Valk, P. Krimpenfort, and P. Borst. 1997. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat. Med. 3:1275-1279.
46. 4 transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell. 103:757-768.
47. Raggers, R.J., I. Vogels, and G. van Meer. 2001. Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor. Biochem. J. 357:859-865.
48. 4 secretion from normal murine mast cells by a probenecid-sensitive and multidrug resistance-associated protein-independent mechanism. J. Immunol. 158:4916-4920.
49. Bandeira-Melo, C., J. Hall, J.F. Penrose, and P.F. Weller. 2002. Cysteinyl leukotrienes induce IL-4 release from cord blood-derived human eosinophils. J. Allergy Clin. Immunol. 109:975-979.
50. Sabin, E.A., M.A. Kopf, and E.J. Pearce. 1996. Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils. J. Exp. Med. 184:1871-1878.